Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib + Chemotherapy in Pediatric Solid Tumors
NCT03628131Phase 2Unknown
- Sponsor
- Samsung Medical Center
- Start
- Oct 2018
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in solid tumor, neuroblastoma, brain tumor, sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
pazopanib
03
Conditions
solid tumorneuroblastomabrain tumor
Beyond the preview
Go deeper on NCT03628131.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03628131.